Rodgers Richard J — SEC Form 4 filings
SEC reporting owner CIK 1313397. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-06-13 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NOVAVAX INC (NVAX) | Director | 6 | — | — | 16 |
| ARDELYX, INC. (ARDX) | Director | 4 | — | — | 9 |
| Opus Genetics, Inc. (IRD) | Director | 3 | — | — | 5 |
Form 4 filings — Rodgers Richard J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | NOVAVAX INC (NVAX) | Option exercise (M): 18,880 · Grant/award (A): 21,270 (derivative) @ $0 · Grant/award (A): 14,180 (derivative) @ $0 · Option exercise (M): 18,880 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | ARDELYX, INC. (ARDX) | Grant/award (A): 26,455 @ $0 · Grant/award (A): 39,715 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 24,367 @ $0 | EDGAR |
| 2025-10-30 | 4 | NOVAVAX INC (NVAX) | Option exercise (M): 3,800 · Option exercise (M): 3,800 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | NOVAVAX INC (NVAX) | Grant/award (A): 28,326 (derivative) @ $6.42 · Grant/award (A): 18,884 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | ARDELYX, INC. (ARDX) | Grant/award (A): 21,468 @ $0 · Grant/award (A): 41,551 @ $0 · Grant/award (A): 54,059 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | NOVAVAX INC (NVAX) | Option exercise (M): 10,420 @ $0 · Option exercise (M): 10,420 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 79,504 @ $0 · Grant/award (A): 79,592 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 100,000 @ $0.55 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | NOVAVAX INC (NVAX) | Option exercise (M): 3,800 @ $0 · Option exercise (M): 3,800 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | ARDELYX, INC. (ARDX) | Grant/award (A): 12,204 @ $0 · Grant/award (A): 40,243 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | NOVAVAX INC (NVAX) | Option exercise (M): 6,670 @ $0 · Option exercise (M): 6,670 (derivative) @ $0 · Grant/award (A): 15,630 (derivative) @ $15.86 · Grant/award (A): 10,420 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Ocuphire Pharma, Inc. (OCUP) | Grant/award (A): 41,143 @ $0 · Grant/award (A): 35,181 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1313397 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →